Company Filing History:

36 out of 1,777

Novo Nordisk A/s

Years Active: 1997-2000

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6166009 - N-substituted azaheterocyclic carboxylic acids and esters thereof (2000-12-26),

2. 6133268 - 1,4-disubstituted piperazines (2000-10-17),

3. 6114354 - N-substituted azaheterocyclic compounds (2000-09-05),

4. 6110913 - N-substituted azaheterocyclic carboxylic acids and esters thereof (2000-08-29),

5. 6100253 - Tricycle substituted with azaheterocyclic carboxylic acids (2000-08-08),

6. 6071901 - Substituted dibenz[b,f]azepines and uses thereof (2000-06-06),

7. 6066632 - Heterocyclic compounds (2000-05-23),

8. 6060468 - N-substituted azaheterocyclic compounds (2000-05-09),

9. 6054458 - Heterocyclic compounds (2000-04-25),

10. 6048856 - Heterocyclic compounds (2000-04-11),

11. 6043239 - Heterocyclic compounds (2000-03-28),

12. 6040318 - Tricycle substituted with azaheterocyclic carboxylic acids (2000-03-21),

13. 6040302 - 1,4-disubstituted piperazines (2000-03-21),

14. 6017915 - Heterocyclic compounds (2000-01-25),

15. 6004983 - N-substituted azaheterocyclic compounds (1999-12-21),

Title: Unveiling the Innovation Journey of Tine Krogh Jo Slashedrgensen

Introduction:

Tine Krogh Jo Slashedrgensen, a prolific inventor hailing from Herlev, Denmark, has left an indelible mark in the realm of patents with an impressive portfolio of 39 patents. His groundbreaking inventions have significantly contributed to the healthcare industry, particularly in the treatment of painful, hyperalgesic, and inflammatory conditions.

Latest Patents:

Among his latest patents is the development of novel N-substituted azaheterocyclic carboxylic acids and esters thereof. These compounds, comprising a substituted alkyl chain as part of the N-substituent, hold promise for the clinical treatment of conditions where C-fibers play a pivotal role in inducing neurogenic pain or inflammation. Additionally, Tine patented 1,4-disubstituted piperazines, which exhibit potential in addressing painful and inflammatory conditions as well as indications associated with insulin antagonising peptides.

Career Highlights:

Tine Krogh Jo Slashedrgensen has made significant contributions while working at renowned companies such as Novo Nordisk A/S. His innovative spirit and dedication to advancing medical science have propelled him to the forefront of pharmaceutical research and development. His patents stand as a testament to his unwavering commitment to improving healthcare outcomes.

Collaborations:

Throughout his illustrious career, Tine has collaborated with esteemed professionals in the field, including Knud Erik Andersen and Uffe Bang Olsen. Together, they have pooled their expertise to push the boundaries of pharmaceutical innovation and pave the way for novel treatment solutions.

Conclusion:

In conclusion, Tine Krogh Jo Slashedrgensen's inventive prowess and relentless pursuit of scientific excellence have established him as a trailblazer in the field of pharmaceutical innovation. His patents not only reflect his technical acumen but also highlight his dedication to addressing unmet medical needs. Tine's remarkable journey serves as inspiration for aspiring inventors and underscores the transformative power of innovation in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.